Doncaster Royal Infirmary is a district general hospital of 800 beds, located in Doncaster, South Yorkshire, England. It is managed by Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust.

There are 800 beds in Doncaster Royal Infirmary.

During the past decade, Doncaster Royal Infirmary conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doncaster Royal Infirmary" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Medical Research Council" with 2 trials sponsored, "University of Leeds" with 2 trials sponsored and "Vital Therapies, Inc." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doncaster Royal Infirmary" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Arthritis Research UK" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "British Heart Foundation" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Doncaster Royal Infirmary" are "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Colitis, Ulcerative" (2 trials), "Leukemia" (2 trials) and "Pain" (2 trials). Many other conditions were trialed in "Doncaster Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Doncaster Royal Infirmary" are "Drug" (24 trials), "Procedure" (12 trials), "Biological" (9 trials), "Other" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (4 trials), "capecitabine" (4 trials), "fludarabine phosphate" (4 trials), "quality-of-life assessment" (4 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Doncaster Royal Infirmary" are 32 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Doncaster Royal Infirmary". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Doncaster Royal Infirmary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Doncaster Royal Infirmary, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".